marketcaparena

REVB

REVELATION BIOSCIENCES, INC.

Company overview

Market capitalization
$3.36M
Employees
8
Latest publication
2026-09-29
About REVELATION BIOSCIENCES, INC.

Revelation Biosciences, Inc. operates as a clinical-stage life science company that focuses on the rebalancing inflammation to optimize health. The company's lead product candidate is lead product candidate Gemini, a proprietary formulation platform of phosphorylated hexaacyl disaccharide (PHAD), an established Toll-like receptor 4 (TLR) agonist that works by modulating and rebalancing a dysregulated inflammatory response. It also engages in the prevention and treatment of disease by developing and commercializing therapeutics that modulate the innate immune system, including GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease. The company was formerly known as Petra Acquisition, Inc. and changed its name to Revelation Biosciences, Inc. in January 2022. Revelation Biosciences, Inc. was incorporated in 2019 and is based in San Diego, California.

Company website

Financial statements

Income Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
Research Development1,376,861USD964,189USD922,857,000,000USD1,317,980,000,000USD858,830,000,000USD605,504,000,000USD830,981,000,000USD1,394,929,000,000USD
Total Operating Expenses3,092,500USD2,571,587USD1,943,011,000,000USD2,461,229,000,000USD2,094,987,000,000USD1,753,888,000,000USD1,796,686,000,000USD2,522,397,000,000USD
Net Income-3,009,051USD-2,511,007USD-1,907,176,000,000USD-2,444,382,000,000USD-2,051,085,000,000USD-1,725,719,000,000USD-2,600,000USD-1,400,000USD
SourceDisclosurePreliminaryDisclosurePreliminaryDisclosurePreliminaryDisclosurePreliminaryDisclosurePreliminaryDisclosurePreliminaryDisclosurePreliminaryDisclosurePreliminary

Income Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
Total Revenue0USD0USD0USD0USD0USD—95,812,000USD85,113,000USD
Cost Of Revenue27,058USD27,923USD25,049USD40,008USD69,166USD——0USD
Gross Profit-27,058USD-27,923USD-25,049USD-40,008USD-69,166USD—90,905,000USD80,983,000USD
Research Development4,063,857USD3,548,996USD4,145,902USD5,377,400USD6,914,756USD2,561USD——
Selling General Administrative5,006,957USD4,426,113USD4,510,762USD5,487,111USD5,035,729USD145,492USD36,336,000USD33,982,000USD
Total Operating Expenses9,070,814USD7,975,109USD8,656,664USD10,864,511USD11,950,485USD145,492USD3,638USD42,089,000USD
Operating Income-9,070,814USD-7,975,109USD-8,656,664USD-10,864,511USD-11,950,485USD-145,492USD-3,638USD38,894,000USD
Income Before Tax-8,913,649USD-15,038,536USD-120,254USD-10,829,549USD-11,986,837USD-136,408USD-3,638USD37,052,000USD
Net Income-8,913,649USD-15,038,536USD-120,254USD-10,829,549USD-11,986,837USD-136,408USD-3,638USD27,627,000USD
Net Income From Continuing Ops-8,913,649USD-15,038,536USD875,063USD-10,829,549USD-11,986,837USD—31,698,000USD27,627,000USD
Ebit-9,070,814USD-7,975,109USD-8,656,664USD-10,864,511USD-11,950,485USD-145,492USD-175,500USD0USD
Ebitda-9,043,756USD-7,947,186USD-8,631,615USD-10,839,463USD-11,933,703USD-145,492USD-3,638USD—
Depreciation And Amortization27,058USD27,923USD25,049USD25,048USD16,782USD3,796USD171,860USD—
Reconciled Depreciation27,058USD27,923USD25,049USD25,048USD16,782USD———
Total Other Income Expense Net157,165USD-7,063,427USD8,536,410USD34,962USD-36,352USD9,084USD2USD-1,842,000USD
Selling And Marketing Expenses——25,049USD——144,257USD——
Income Tax Expense——1USD-34,962USD-219,776USD-3,796USD-171,860USD9,425,000USD
Interest Expense———34,962USD41,759USD0USD0USD0USD
Net Income Applicable To Common Shares————-2,130,625USD-3,795,693USD31,698,000USD27,627,000USD
Other Operating Expenses—————145,492USD—4,070,000USD
Unclassified Operating Expenses——————-36,332,362USD4,037,000USD
Interest Income——————129,341,000USD106,973,000USD
Net Interest Income——————92,868,000USD82,842,000USD
Tax Provision——————11,600,000USD9,425,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
Total Assets12,497,932USD15,044,282USD11,582,924USD12,856,342USD5,395,090USD3,970,271USD6,622,049USD6,740,140USD
Cash And Equivalents11,482,792USD14,113,415USD10,700,331USD12,708,489USD5,173,871USD3,704,611USD6,499,018USD6,541,052USD
Total Current Assets11,684,516USD14,206,035USD10,811,628USD12,832,423USD5,359,920USD3,927,881USD6,565,717USD6,658,898USD
Other Current Assets201,724USD92,620USD111,297USD123,934USD186,049USD223,270USD66,699USD117,846USD
Other Non Current Assets30,941USD30,941USD30,941USD—————
Total Liabilities2,430,946USD2,055,329USD2,721,929USD1,854,507USD1,569,306USD1,089,519USD1,913,667USD4,066,523USD
Total Current Liabilities1,880,400USD1,417,146USD1,998,158USD1,854,507USD1,569,306USD1,089,519USD1,913,667USD4,066,523USD
Other Current Liabilities759,937USD468,082USD1,397,644USD819,381USD739,626USD463,632USD1,127,800USD934,372USD
Total Stockholder Equity10,066,986USD12,988,953USD8,860,995USD11,001,835USD3,825,784USD2,880,752USD4,708,382USD2,673,617USD
Total Equity Including Noncontrolling Interest10,066,986USD12,988,953USD8,860,995USD11,001,835USD3,825,784USD2,880,752USD4,708,382USD2,673,617USD
Property Plant Equipment Net782,475USD807,306USD740,355USD23,919USD35,170USD42,390USD56,332USD81,242USD
Accounts Payable931,093USD828,203USD577,501USD1,034,951USD828,894USD625,058USD783,621USD3,127,348USD
Short Term Debt189,370USD120,861USD23,013USD—————
Common Stock3,908USD3,908USD1,584USD3,586USD1,535USD964USD522USD4,292USD
Retained Earnings-55,751,722USD-52,428,338USD-49,419,287USD-46,908,281USD-45,001,105USD-42,556,723USD-40,505,638USD-38,779,919USD
SourceDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinal

Balance sheet Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20182018-12-31 · USDFY 20172017-12-31 · USD
Total Assets11,582,924USD6,622,049USD12,212,609USD5,503,415USD48,385,887USD74,162,206USD2,455,211,000USD2,098,845,000USD
Cash And Equivalents10,700,331USD6,499,018USD11,991,701USD5,252,979USD78,532USD11,734USD——
Total Current Assets10,811,628USD6,565,717USD12,147,525USD5,413,282USD83,366USD651,291USD143,296,000USD78,080,000USD
Other Current Assets111,297USD66,699USD84,691USD73,132USD——6,854,000USD5,868,000USD
Other Non Current Assets30,941USD———————
Total Liabilities2,721,929USD1,913,667USD5,564,894USD4,450,962USD8,397,377USD6,344,910USD——
Total Current Liabilities1,998,158USD1,913,667USD5,564,894USD4,450,962USD5,486,117USD3,433,650USD2,120,760,000USD1,796,021,000USD
Other Current Liabilities1,397,644USD1,127,800USD1,152,460USD985,497USD—33,772USD——
Total Stockholder Equity8,860,995USD4,708,382USD6,647,715USD1,052,453USD-7,822,654USD-5,692,029USD264,891,000USD188,277,000USD
Total Equity Including Noncontrolling Interest8,860,995USD4,708,382USD6,647,715USD1,052,453USD39,988,510USD67,817,296USD——
Property Plant Equipment Net740,355USD56,332USD65,084USD90,133USD——4,283,000USD4,227,000USD
Accounts Payable577,501USD783,621USD1,359,898USD554,205USD784,800USD—1,320,000USD929,000USD
Short Term Debt23,013USD—————30,473,000USD—
Common Stock1,584USD522USD265USD683USD1,820USD1,820USD59,087,000USD49,272,000USD
Retained Earnings-49,419,287USD-40,505,638USD-25,467,102USD-25,346,848USD-7,824,474USD-5,693,849USD62,878,000USD35,060,000USD
Deferred Revenue Non Current————2,911,260USD2,911,260USD——
Cash And Short Term Investments—————537,021USD——
Short Term Investments—————525,287USD187,558,000USD163,226,000USD
Intangible Assets——————3,627,000USD4,337,000USD
Total Liab——————2,190,320,000USD1,910,568,000USD
Other Liab——————5,862,000USD6,113,000USD
Good Will——————26,815,000USD26,815,000USD
Other Assets——————2,084,934,000USD1,817,010,000USD
Cash——————136,442,000USD72,200,000USD
Short Long Term Debt——————30,473,000USD—
Long Term Debt——————94,171,000USD108,434,000USD
Long Term Investments——————192,256,000USD168,376,000USD
Net Receivables——————6,854,000USD5,868,000USD
Net Tangible Assets——————234,449,000USD157,125,000USD
Unclassified Current Assets——————-194,412,000USD-169,082,000USD
Unclassified Current Liabilities——————2,058,494,000USD1,795,092,000USD
Unclassified Equity——————142,926,000USD103,945,000USD
SourceDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicAmendmentDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicAmendmentLegacy providerLegacyLegacy providerLegacy

Cash flow Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
Depreciation7,203USD5,852USD6,765USD7,220USD7,221USD7,221USD7,220USD7,220USD
Stock Based Compensation470,997USD370,166USD874USD873USD223,455USD72,566USD32,095USD32,095USD
Change To Liabilities-712,662USD———-822,731USD———
Change In Working Capital177,603USD149,453USD306,761USD517,051USD-315,134USD-2,099,152USD-7,048,693USD5,851,238USD
Operating Cash Flow-3,214,851USD———-2,794,407USD———
Capital Expenditures-71,879USD0USD0USD0USD—-17,691USD-17,686USD-19,172USD
Investing Cash Flow-71,879USD———————
Financing Cash Flow6,699,814USD———————
Change In Cash3,413,084USD-2,008,158USD7,534,618USD1,469,260USD-2,794,407USD-42,034USD-5,532,006USD-2,478,682USD
End Cash Flow14,113,415USD———3,704,611USD———
Net Income—-2,511,006USD-1,907,176USD-2,444,382USD—-1,725,719USD-2,241,565USD-8,389,819USD
Other Non Cash Items—18,543USD3,875USD-43USD—-2,557USD-6,041USD20,584USD
Total Cash From Operating Activities—-1,966,992USD-1,588,901USD-1,919,281USD—-3,747,641USD-9,256,984USD-2,478,682USD
Free Cash Flow—-1,966,990USD-1,588,901USD-1,919,281USD—-3,729,950USD-9,274,670USD-2,478,682USD
Total Cash From Financing Activities—-41,166USD9,123,519USD3,388,541USD—3,687,918USD3,742,666USD5,417,180USD
Dividends Paid—-5,945,576,472USD-2,769,742USD-3,181,786USD————
Issuance Of Capital Stock—0USD0USD3,388,244USD—0USD0USD0USD
Begin Period Cash Flow—12,708,489USD5,173,871USD3,704,611USD—6,541,052USD12,073,058USD14,551,740USD
End Period Cash Flow—10,700,331USD12,708,489USD5,173,871USD—6,499,018USD6,541,052USD12,073,058USD
Other Cashflows From Financing Activities—5,945,576,472USD2,769,742USD3,182,083USD—9,104,971USD3,742,666USD5,392,180USD
Investments——0USD0USD—17,689USD-17,688USD0USD
Total Cashflows From Investing Activities——281,967USD-281,967USD—17,689USD-17,688USD—
Other Cashflows From Investing Activities——-281,967USD281,967USD—-19,132,657USD-353,544USD301,139USD
Unclassified Financing Cash Flow——9,123,519USD——-5,417,053USD——
Sale Purchase Of Stock—————0USD0USD0USD
Unclassified Investing Cash Flow—————19,150,348USD——
SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
Depreciation27,058USD27,923USD25,049USD25,048USD——1,748,000USD1,489,000USD
Stock Based Compensation595,368USD168,850USD155,721USD301,116USD————
Change To Liabilities63,636USD-3,512,197USD911,623USD-1,259,029USD2,287,742USD33,773USD0USD0USD
Change In Working Capital-281,659USD-558,285USD738,101USD-96,998USD2,287,742USD33,773USD3,638USD-986,000USD
Operating Cash Flow-8,269,581USD-18,321,276USD-7,286,286USD-11,219,396USD-725,618USD-215,074USD——
Financing Cash Flow12,470,894USD12,847,764USD14,025,008USD15,197,646USD-24,948,161USD74,264,723USD——
Change In Cash4,201,313USD-5,492,683USD6,738,722USD3,978,250USD66,798USD—10,673,000USD65,700,000USD
End Cash Flow10,700,331USD6,499,018USD11,991,701USD5,252,979USD78,532USD———
Capital Expenditures—-19,171USD————-526,000USD-861,000USD
Investing Cash Flow—-19,171USD——25,740,577USD-74,037,915USD——
Net Investments————525,287USD-527,000USD——
Unclassified Investing Cash Flow————25,215,290USD-73,510,915USD——
Net Common Stock Issuance————-35,500,000USD———
Unclassified Financing Cash Flow————10,551,839USD—338,179,000USD48,435,000USD
Net Income——————-3,638USD27,627,000USD
Change To Account Receivables——————-814,000USD-986,000USD
Total Cash From Operating Activities——————41,086,000USD32,579,000USD
Investments——————-368,602,000USD-294,852,000USD
Total Cash From Financing Activities——————338,189,000USD327,973,000USD
End Period Cash Flow——————74,243,480USD—
Other Cashflows From Financing Activities——————10,000USD293,888,000USD
Unclassified Operating Cash Flow——————39,338,000USD4,449,000USD
Total Cashflows From Investing Activities———————-294,852,000USD
Net Borrowings———————-14,350,000USD
Other Cashflows From Investing Activities———————1,470,000USD
SourceDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicAmendmentDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicAmendmentLegacy providerLegacyLegacy providerLegacy

Cash flow YTD

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USDQ3 20232023-09-30 · USDQ2 20232023-06-30 · USDQ3 20222022-09-30 · USDQ2 20222022-06-30 · USD
Depreciation21,206USD14,441USD20,702USD13,482USD18,787USD12,525USD18,786USD12,524USD
Stock Based Compensation225,202USD224,328USD96,284USD64,189USD123,626USD91,530USD268,755USD228,080USD
Change To Liabilities-98,255USD-342,901USD-1,361,898USD5,694,692USD770,574USD-97,949USD-1,305,183USD-431,711USD
Change In Working Capital179,095USD-74,077USD1,734,295USD-119,627USD641,431USD200,698USD-403,698USD-219,160USD
Operating Cash Flow-6,302,589USD-4,713,688USD-14,573,635USD-5,316,651USD-5,283,450USD-3,566,769USD-10,271,929USD-8,540,511USD
Financing Cash Flow12,512,060USD3,388,541USD9,159,846USD5,417,180USD14,025,008USD14,025,008USD15,192,646USD10,741,598USD
Change In Cash6,209,471USD-1,325,147USD-5,450,649USD81,357USD8,741,558USD10,458,239USD4,920,717USD2,201,087USD
End Cash Flow12,708,489USD5,173,871USD6,541,052USD12,073,058USD13,994,537USD15,711,218USD6,195,446USD3,475,816USD
Capital Expenditures——-36,860USD-19,172USD————
Investing Cash Flow——-36,860USD-19,172USD————
SourceDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicAmendmentDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinal

Operating metrics

No operating metrics are currently published for this company.

Revenue breakdown

No revenue breakdown is currently published for this company.

Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.